Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
NATCOPHARM
NATCOPHARM
791.85+6.7 (+0.85%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

98.4 / 100

Value Score

82.7 / 100

Price Momentum Score

41.8 / 100

QVM Score

93.9 / 100

Key Metrics

Market Cap
15533.60
P/E (TTM)
13.57
P/B
1.68
P/S (TTM)
4.46
EV/EBITDA
12.72
CAPE (5Y)
12.56
ROE (TTM)
16.86
ROCE (TTM)
13.80
ROA (TTM)
14.40
Avg 3Y ROE
23.59
Earnings 3Y CAGR
12.49
Sales 3Y CAGR
5.55
Sales 5Y CAGR
12.91
Debt/Equity
0.08
Consensus TP
991.86
Strong Buy %
25.00
Promoter Holding
49.39
Pledged %
0.00

Share Price

Track Natco Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

791.856.7 (0.85%) D
-4.24% in past 1 year
1 Week returns: 0.87 %
Low
773.6
High
809.8
1 Month returns: -4.69 %
Low
773.6
High
850.9
1 Year returns: -4.24 %
Low
773.6
High
1,216.9
3 Year CAGR: -0.69 %
Low
654.7
High
1,625.8
5 Year CAGR: -1.11 %
Low
497.9
High
1,625.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Natco Pharma Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 13.57 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -55.46%

What is P/E Ratio?

Median: 30.47
Value 13.57
-0.82614.73
Analysts have been raising forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has increased by 1.48% in the last 3 months, indicating earnings momentum

What is Earnings upgrade (3M)?

41.63May 2643.24Jun 2643.68Jul 2644.67Aug 2645.71Sep 2646.17Oct 26
Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Low dividend yield

The company has a low dividend yield of 0.63%

What is Dividend yield?

Neutral
Company's earnings are of moderate quality

Earnings quality score of 64.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

64.0 / 100

No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for Natco Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
02k4k6k2.7 K CrMar 20234.0 K CrMar 20244.4 K CrMar 20254.1 K CrMar 2026
Profit After Tax FY
01k1k2k2k715.3 CrMar 20231.4 K CrMar 20241.9 K CrMar 20251.4 K CrMar 2026
ROE FY
0%10%20%30%15.7%Mar 202325.9%Mar 202428.0%Mar 202516.9%Mar 2026
EBITDA FY
01k2k3k943.1 CrMar 20231.8 K CrMar 20242.2 K CrMar 20251.4 K CrMar 2026

Natco Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Natco Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Promoter
48.93
48.93
48.91
48.91
48.87
48.87
48.87
48.86
48.81
48.80
48.80
48.82
48.84
49.76
49.71
49.71
49.71
49.71
49.62
49.62
49.56
49.56
49.48
49.48
49.42
49.42
49.39
Indian Promoter
48.93
48.93
48.91
48.91
48.87
48.87
48.87
28.17
48.81
48.80
48.80
48.82
48.84
49.76
49.71
49.71
49.71
49.71
49.62
49.62
49.14
49.14
49.14
49.14
49.14
49.14
49.12
Foreign Promoter
-
-
-
-
-
-
-
20.69
-
-
-
-
-
-
-
-
-
-
-
-
0.42
0.42
0.34
0.34
0.27
0.27
0.27
Institutions
32.24
33.22
33.03
33.21
32.49
29.94
30.31
30.34
28.09
26.95
25.97
26.65
27.28
26.17
26.83
24.97
25.84
25.31
24.26
23.51
22.97
21.16
19.96
20.54
22.82
22.60
22.15
Mutual Funds / UTI
8.50
8.67
9.26
8.92
9.45
9.00
8.82
9.07
7.39
6.75
7.63
8.18
8.50
9.45
7.65
5.20
4.08
2.67
2.37
1.92
1.85
2.11
2.20
1.60
1.72
1.92
2.25
FI/Bank/Insurance
1.06
0.22
0.19
0.19
0.19
0.16
0.16
0.16
0.16
0.00
6.07
6.21
6.42
5.58
6.34
6.04
5.58
5.09
4.23
3.33
3.39
3.43
3.31
3.50
3.30
3.64
3.80
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
21.67
20.40
19.32
18.17
16.35
13.70
12.53
12.26
11.97
11.65
11.67
11.72
11.91
11.03
12.82
13.72
16.14
17.45
17.51
17.94
17.49
15.52
14.09
15.16
17.37
16.99
15.99
Other Institutions
1.02
3.93
4.26
5.92
6.50
7.08
16.78
16.72
16.12
8.54
0.60
0.54
0.46
0.12
0.02
0.02
0.03
0.10
0.15
0.33
0.23
0.10
0.36
0.28
0.43
0.06
0.10
Non-Institution
18.83
17.85
18.07
17.88
18.65
21.19
20.82
20.80
23.10
24.25
25.23
24.53
23.87
24.07
23.46
25.32
24.46
24.97
26.12
26.88
27.46
29.28
30.56
29.97
27.76
27.98
28.46
Bodies Corporate
2.55
1.51
1.53
1.32
1.64
3.21
2.94
2.69
4.16
4.46
3.58
3.07
2.01
2.24
2.30
2.22
1.96
1.54
1.68
1.60
1.64
1.88
1.63
1.41
1.37
1.53
1.59
Others (incl. Retail)
No. of shareholders
16.28
70,689
16.34
78,141
16.54
77,204
16.56
76,824
17.01
84,641
17.98
86,678
17.88
87,509
18.11
87,402
18.94
84,637
19.79
91,197
21.65
1,20,070
21.46
1,34,202
21.86
1,52,489
21.83
1,54,212
21.16
1,62,725
23.10
2,06,464
22.50
2,27,253
23.43
2,50,105
24.44
3,01,356
25.28
3,43,592
25.82
4,03,652
27.40
4,27,963
28.93
4,18,487
28.56
4,22,989
26.39
4,09,675
26.45
4,01,835
26.87
4,02,793

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence
#IndexWeightRank
1Nifty Smallcap250 Quality 501.51%36 / 50
2Nifty Smallcap 500.92%46 / 49
3Nifty 500 Momentum Quality 500.41%47 / 50
4Nifty Smallcap 2500.33%111 / 248
5Nifty 5000.04%331 / 496
6Nifty Total Market0.04%370 / 746
Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Natco Pharma Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
DURGA DEVI NANNAPANENI
Promoter
October-2026
Off Market (Disposal)
16th Oct 2026
0.68 %₹ 10.001.17 lac₹ 11.69 lac
Vistra ITCL India Limited (A/C Neelima Nannapaneni Trust)
Promoter
October-2026
Off Market (Disposal)
16th Oct 2026
2.28 %₹ 10.003.19 lac₹ 31.90 lac
V.C.Nannapaneni
Promoter and Director
October-2026
Off Market (Disposal)
16th Oct 2026
3.54 %₹ 10.0017.94 k₹ 1.79 lac
V S SWATHI KANTAMANI
Promoter Group
October-2026
Off Market (Disposal)
16th Oct 2026
6.22 %₹ 10.0010.00 lac₹ 1.00 cr
NATSOFT INFORMATION SYSTEMS PRIVATE LIMITED
Promoter Group
October-2026
Off Market (Disposal)
16th Oct 2026
1.69 %₹ 10.0048.44 k₹ 4.84 lac
Time Cap Pharma Labs Private Limited
Promoter Group
October-2026
Off Market (Disposal)
16th Oct 2026
6.27 %₹ 10.001.36 lac₹ 13.58 lac
RAJEEV NANNAPANENI
Promoter and Director
October-2026
Off Market (Disposal)
16th Oct 2026
0.43 %₹ 10.0014.29 k₹ 1.43 lac
NEELIMA SITA NANNAPANENI
Promoter
October-2026
Market Purchase (Acquisition)
16th Oct 2026
0.10 %₹ 35.522.38 lac₹ 84.52 lac
NATSOFT INFORMATION SYSTEMS PRIVATE LIMITED
Promoter Group
October-2026
Market Sale (Disposal)
15th Oct 2026
8.81 %₹ 32.0012.00 lac₹ 3.84 cr
V S SWATHI KANTAMANI
Promoter Group
October-2026
Market Sale (Disposal)
15th Oct 2026
8.89 %₹ 32.523.33 lac₹ 1.08 cr
…

Corporate Actions

History of Natco Pharma Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Rights Issue(2 new shares @ ₹750 for 21 existing shares)
    Ex-date: 1st Oct 2026Announced on: 25th Sep 2026
    "ISIN Rights INE987B20018 CUSIP Y6211C165."
  2. Dividend₹ 1.50/share
    Record date: 20th Aug 2026Ex-date: 20th Aug 2026
    Announced on: 14th Aug 2026
  3. Dividend₹ 1.50/share
    Record date: 18th Feb 2026Ex-date: 18th Feb 2026
    Announced on: 12th Feb 2026
  4. Dividend₹ 1.50/share
    Record date: 20th Nov 2025Ex-date: 20th Nov 2025
    Announced on: 14th Nov 2025
  5. Dividend₹ 2/share
    Record date: 19th Aug 2025Ex-date: 19th Aug 2025
    Announced on: 13th Aug 2025

Company Profile

Overview of Natco Pharma Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with a focus on research and development. It develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. Its ...
Key personnel
Mr. Amit Parekh
Chief Financial Officer
Mr. Gnanadeva Chalapathy Gudipati
Senior Vice President - Analytical Research and Development
Shri. Venkat Ramesh Chekuri
Compliance Officer, Company Secretary
Mr. Sunil Kotaru
Senior Vice President - Supply Chain Management
Mr. Sandeep Kumar
Senior Vice President - QA
Mr. Yarramshetty Krishna Rao
Senior Vice President - Operations
Dr. Rampalli Sriram
Senior Vice President - CRD
Shri. Venkat Ramesh Chekuri
Compliance Officer, Company Secretary
View all
Incorporated on
19 Sep 1981
Last Annual
31 Mar 2026
Last Interim
-
No. of Employees
5,060
IPO date
23 Jan 1995
Free Float
8,79,82,175
Phone no.
+914023547532
Address
Natco House, Road No 2, Banjara Hills, HYDERABAD, 500034, India

Frequently Asked Questions

What is the current share price of Natco Pharma Ltd.?
The current share price of Natco Pharma Ltd. is ₹ 791.85 as of 23 Oct 2026.
What is the market capitalisation of Natco Pharma Ltd.?
The market capitalisation of Natco Pharma Ltd. stands at ₹ 15,533.60 Cr.
What is the PE ratio of Natco Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Natco Pharma Ltd. is 13.57 as of the latest trailing twelve months data.
What is the ROE and ROCE of Natco Pharma Ltd.?
Natco Pharma Ltd. has a Return on Equity (ROE) of 16.86% and a Return on Capital Employed (ROCE) of 13.80% as per the latest financial reports.
What is the 52-week high and low of Natco Pharma Ltd.?
The 52-week high of Natco Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Natco Pharma Ltd.?
The dividend yield of Natco Pharma Ltd. is 0.63% based on the current market price.
What is the FII and DII holding in Natco Pharma Ltd.?
Foreign Institutional Investors (FII) hold 15.99%, Domestic Institutional Investors (DII) hold 6.05% and retail/public investors hold 26.87% of Natco Pharma Ltd. shares.
What sector does Natco Pharma Ltd. belong to?
Natco Pharma Ltd. operates in the Healthcare sector. 37.5% of analysts have a Buy or Strong Buy rating on Natco Pharma Ltd. with a consensus target price of ₹ 991.86, implying 25.26% upside from current levels.
What is the beta of Natco Pharma Ltd.?
The beta of Natco Pharma Ltd. is 0.90, indicating its price volatility relative to the broader market. Over the past 1 year, Natco Pharma Ltd. has delivered an absolute return of -2.69%.
What is the RSI of Natco Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Natco Pharma Ltd. is 41.93, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.